96.52

1.24% 1.18

After Hours: 96.68 0.16 +0.17%

Zimmer Biomet Holdings Inc (ZBH)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Zimmer Biomet Holdings Inc stock is traded at $96.52, with a volume of 2.65M. It is up +1.24% in the last 24 hours and up +3.56% over the past month. Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.

Previous Close:

$95.34

Open:

$95.38

24h Volume:

2.65M

Relative Volume:

1.20

Market Cap:

$18.68B

Revenue:

$8.23B

Net Income/Loss:

$705.10M

P/E Ratio:

27.21

EPS:

3.5467

Net Cash Flow:

$1.12B

1W Performance:

+5.60%

1M Performance:

+3.56%

6M Performance:

-1.88%

1Y Performance:

-5.34%

1-Day Range:

$95.09

$97.81

1-Week Range:

$91.40

$97.81

52-Week Range:

$84.59

$108.29

Zimmer Biomet Holdings Inc Stock (ZBH) Company Profile

Name

Zimmer Biomet Holdings Inc

Sector

Healthcare (1110)

Industry

Medical Devices (141)

Phone

(574) 267-6131

Address

345 EAST MAIN STREET, WARSAW, IN

Employee

17,000

Twitter

@zimmerbiomet

Next Earnings Date

2024-10-30

Latest SEC Filings

ZBH's Discussions on Twitter

Compare ZBH vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ZBH Zimmer Biomet Holdings Inc	96.52	18.03B	8.23B	705.10M	1.12B	3.5467
ABT Abbott Laboratories	101.05	174.29B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	345.88	129.89B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	88.12	111.97B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	63.82	91.83B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	78.20	44.90B	6.07B	1.06B	1.34B	1.8063

Zimmer Biomet Holdings Inc Stock (ZBH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-23-26	Downgrade	BTIG Research	Buy → Neutral
Feb-20-26	Initiated	William Blair	Mkt Perform
Jan-09-26	Downgrade	Goldman	Neutral → Sell
Jan-06-26	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-05-26	Upgrade	Evercore ISI	In-line → Outperform
Dec-16-25	Downgrade	Robert W. Baird	Outperform → Neutral
Nov-06-25	Downgrade	JP Morgan	Overweight → Neutral
Sep-18-25	Initiated	Rothschild & Co Redburn	Buy
Jul-15-25	Upgrade	Roth Capital	Neutral → Buy
Dec-17-24	Upgrade	JP Morgan	Neutral → Overweight
Sep-10-24	Initiated	Wolfe Research	Peer Perform
Jul-01-24	Downgrade	Piper Sandler	Overweight → Neutral
May-30-24	Initiated	Goldman	Neutral
May-21-24	Upgrade	Argus	Hold → Buy
Jan-04-24	Downgrade	Evercore ISI	Outperform → In-line
Oct-20-23	Initiated	ROTH MKM	Neutral
Aug-28-23	Upgrade	BTIG Research	Neutral → Buy
May-03-23	Upgrade	BofA Securities	Underperform → Neutral
Apr-11-23	Upgrade	Evercore ISI	In-line → Outperform
Mar-31-23	Upgrade	Jefferies	Underperform → Hold
Mar-29-23	Initiated	UBS	Sell
Mar-10-23	Upgrade	Piper Sandler	Neutral → Overweight
Jan-09-23	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Jan-05-23	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-03-23	Downgrade	Evercore ISI	Outperform → In-line
Nov-23-22	Upgrade	Wells Fargo	Underweight → Equal Weight
Oct-18-22	Initiated	Barclays	Underweight
Oct-12-22	Initiated	Jefferies	Underperform
May-27-22	Downgrade	Needham	Buy → Hold
Apr-13-22	Downgrade	Truist	Buy → Hold
Apr-01-22	Downgrade	Citigroup	Buy → Neutral
Mar-02-22	Resumed	BofA Securities	Underperform
Mar-02-22	Downgrade	Loop Capital	Buy → Hold
Feb-08-22	Downgrade	Canaccord Genuity	Buy → Hold
Feb-08-22	Reiterated	Citigroup	Buy
Feb-08-22	Reiterated	Deutsche Bank	Hold
Feb-08-22	Reiterated	JMP Securities	Mkt Outperform
Feb-08-22	Reiterated	JP Morgan	Neutral
Feb-08-22	Reiterated	RBC Capital Mkts	Sector Perform
Feb-08-22	Reiterated	Stifel	Buy
Feb-08-22	Reiterated	Truist	Buy
Feb-08-22	Reiterated	UBS	Neutral
Feb-08-22	Reiterated	Wells Fargo	Underweight
Feb-02-22	Downgrade	UBS	Buy → Neutral
Jan-19-22	Downgrade	Wells Fargo	Equal Weight → Underweight
Jan-10-22	Downgrade	Mizuho	Buy → Neutral
Jan-07-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jan-04-22	Downgrade	Piper Sandler	Overweight → Neutral
Dec-10-21	Initiated	RBC Capital Mkts	Sector Perform
Dec-09-21	Downgrade	Needham	Strong Buy → Buy
Dec-07-21	Initiated	Loop Capital	Buy
Nov-23-21	Downgrade	Argus	Buy → Hold
Sep-14-21	Resumed	Raymond James	Mkt Perform
May-25-21	Initiated	Barclays	Overweight
Apr-09-21	Upgrade	Northland Capital	Market Perform → Outperform
Jan-04-21	Upgrade	Evercore ISI	In-line → Outperform
Dec-18-20	Reiterated	Needham	Strong Buy
Oct-20-20	Initiated	Northland Capital	Market Perform
Sep-11-20	Initiated	Wolfe Research	Outperform
Aug-05-20	Reiterated	Needham	Strong Buy
Apr-28-20	Downgrade	Guggenheim	Buy → Neutral
Apr-09-20	Downgrade	Evercore ISI	Outperform → In-line
Apr-07-20	Reiterated	Needham	Strong Buy
Mar-05-20	Initiated	Citigroup	Buy
Feb-13-20	Initiated	Goldman	Buy
Jan-08-20	Initiated	SunTrust	Buy
Jan-07-20	Upgrade	Piper Jaffray	Neutral → Overweight
Jan-07-20	Upgrade	Piper Sandler	Neutral → Overweight
Dec-04-19	Upgrade	Raymond James	Outperform → Strong Buy
Oct-07-19	Upgrade	BTIG Research	Neutral → Buy
Sep-18-19	Upgrade	Canaccord Genuity	Hold → Buy
Aug-12-19	Upgrade	Argus	Hold → Buy
Jul-30-19	Upgrade	Barclays	Underweight → Equal Weight
Jul-29-19	Upgrade	Robert W. Baird	Neutral → Outperform
Jun-11-19	Upgrade	Bernstein	Underperform → Mkt Perform
Apr-24-19	Upgrade	Needham	Buy → Strong Buy

View All

Zimmer Biomet Holdings Inc Stock (ZBH) Latest News

09:55 AM

Zimmer Biomet stock (US98956P1021): Is its knee implant dominance strong enough to unlock new upside - AD HOC NEWS

09:55 AM

03:26 AM

Leerink Partners initiates coverage of Zimmer Biomet Holdings (ZBH) with market perform recommendation - MSN

03:26 AM

Apr 13, 2026

Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Apr 13, 2026

Zimmer Biomet stock (US98956P1021): Is supply chain resilience now the real test for medtech growth? - AD HOC NEWS

Apr 13, 2026

Leerink Partners Begins Coverage on Zimmer Biomet (NYSE:ZBH) - MarketBeat

Apr 13, 2026

Leerink initiates Zimmer Biomet stock coverage with Market Perform By Investing.com - Investing.com India

Apr 13, 2026

Leerink initiates Zimmer Biomet stock coverage with Market Perform - Investing.com

Apr 13, 2026

Apr 11, 2026

Zimmer Biomet Appoints Dr. Jonathan M. Vigdorchik as Chief Science, Technology and Medical Affairs Officer - Florida Hospital News and Healthcare Report

Apr 11, 2026

Wall Street Zen Upgrades Zimmer Biomet (NYSE:ZBH) to Buy - MarketBeat

Apr 11, 2026

Apr 10, 2026

Zimmer Biomet’s Quarterly Earnings Preview: What You Need to Know - Yahoo Finance

Apr 10, 2026

SNDL vs. Zimmer Biomet: A Financial Comparison - National Today

Apr 10, 2026

Douglas Lane & Associates LLC Raises Holdings in Zimmer Biomet Holdings, Inc. $ZBH - MarketBeat

Apr 10, 2026

Comerica Bank Lifts Stake in Zimmer Biomet Holdings, Inc. (ZBH) Amid Robotics Drive - MSN

Apr 10, 2026

Apr 09, 2026

Zimmer Biomet Announces Webcast and Conference Call of First Quarter 2026 Financial Results - BioSpace

Apr 09, 2026

Zimmer Biomet (ZBH) Valuation Check After Mixed Returns And Robotics Growth Plans - Sahm

Apr 09, 2026

Zimmer Biomet (ZBH) Valuation Check After New Technology Leadership And Robotic Shoulder Surgery Milestones - Yahoo Finance

Apr 09, 2026

Apr 08, 2026